Raju S. Kucherlapati, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 75,000 shares at $11.08 ($830K) on 2007-10-10, disclosed to the SEC on 2007-10-12.
Scheduled sale ($830k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 16,300 | $179K | 21.6% |
| 2 | $11.01 | 5,000 | $55K | 6.6% |
| 3 | $11.02 | 2,400 | $26K | 3.2% |
| 4 | $11.03 | 3,000 | $33K | 4.0% |
| 5 | $11.04 | 2,420 | $27K | 3.2% |
| 6 | $11.05 | 5,380 |
| $59K |
| 7.2% |
| 7 | $11.06 | 2,300 | $25K | 3.1% |
| 8 | $11.07 | 1,500 | $17K | 2.0% |
| 9 | $11.08 | 2,400 | $27K | 3.2% |
| 10 | $11.09 | 1,500 | $17K | 2.0% |
| 11 | $11.10 | 12,036 | $134K | 16.1% |
| 12 | $11.11 | 15,764 | $175K | 21.1% |
| 13 | $11.12 | 5,000 | $56K | 6.7% |
| Total | $11.06 avg | 75,000 | $830K | 100% |
| Filing → |
| GLS | BUY | 2022-01-19 | $100K | — | Filing → |
| AVEO | BUY | 2012-12-17 | $101K | — | Filing → |
| AVEO | BUY | 2012-02-21 | $69K | — | Filing → |